Russia Sputnik V Covid-19 Vaccine Trial Continues, Ministry Says

Oct. 29, 2020, 3:26 PM

Phase 3 trial of Russia’s Sputnik V vaccine against Covid-19 is continuing, Health Ministry says in text message.

  • Supplies of vaccine are adequate for the trial to continue, RIA Novosti reports, citing Alexander Gintsburg, director of the Gamaleya Institute, developer of the inoculation
  • Trial on track to reach target of 40,000 subjects, Health Ministry says, according to RIA
  • Trials continuing, reports of suspension due to shortage are false, says Alexey Butylin, managing director of Crocus Medical, research organization that’s working with Gamaleya on vaccine trial
  • READ: Russia Covid Vaccine Trial Paused Due to Dose Shortage: Reuters

To contact the reporters ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.